High frequency and molecular epidemiology of metallo-β-lactamase-producing gram-negative bacilli in a tertiary care hospital in Lahore, Pakistan

[1]  Yanping Han,et al.  Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. , 2017, Experimental and therapeutic medicine.

[2]  O. KhalifaHazim,et al.  High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt. , 2017 .

[3]  M. Taherikalani,et al.  Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran , 2017, Journal of epidemiology and global health.

[4]  A. Gales,et al.  Detection and analysis of different interactions between resistance mechanisms and carbapenems in clinical isolates of Klebsiella pneumoniae , 2017, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[5]  S. Seo,et al.  Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States , 2017, Antimicrobial Agents and Chemotherapy.

[6]  Samyyia Abrar,et al.  Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan. , 2017, Microbial pathogenesis.

[7]  Z. Bhutta,et al.  Antimicrobial resistance-a threat to neonate survival. , 2016, The Lancet. Global health.

[8]  B. Nadjm,et al.  High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs , 2016, Medicine.

[9]  R. Sekar,et al.  Carbapenem resistance in a rural part of southern India: Escherichia coli versus Klebsiella spp. , 2016, The Indian journal of medical research.

[10]  N. Aksu,et al.  Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey , 2016, Annals of Clinical Microbiology and Antimicrobials.

[11]  N. Aksu,et al.  Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey , 2016, Annals of Clinical Microbiology and Antimicrobials.

[12]  A. Zafar,et al.  Phenotypic Detection of Metallo-Beta-Lactamases in Carbapenem Resistant Acinetobacter baumannii Isolated from Pediatric Patients in Pakistan , 2016, Journal of pathogens.

[13]  B. Jia,et al.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  T. Gupta,et al.  Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center , 2016, Indian Journal of Medical and Paediatric Oncology.

[15]  A. Peleg,et al.  Distribution of β-Lactamase Genes Among Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated From Patients in Turkey , 2015, Annals of laboratory medicine.

[16]  P. Hawkey,et al.  Multidrug-resistant Gram-negative bacteria: a product of globalization. , 2015, The Journal of hospital infection.

[17]  B. Gu,et al.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia. , 2015, Journal of thoracic disease.

[18]  Shan-Chwen Chang,et al.  Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan , 2015, PloS one.

[19]  M. Alikhani,et al.  Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU) , 2015, Saudi journal of biological sciences.

[20]  D. Raoult,et al.  New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  M. Al-agamy,et al.  Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients , 2014, BioMed research international.

[22]  K. Seme,et al.  Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  P. Nordmann,et al.  Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.

[24]  T. Wichelhaus,et al.  Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. , 2011, The Journal of antimicrobial chemotherapy.

[25]  J. Turton,et al.  Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. , 2011, The Journal of hospital infection.

[26]  G. Cornaglia,et al.  Metallo-β-lactamases: a last frontier for β-lactams? , 2011, The Lancet. Infectious diseases.

[27]  Afreenish Hassan,et al.  Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan. , 2010, Journal of infection in developing countries.

[28]  G. Cornaglia,et al.  New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[30]  V. Miriagou,et al.  An Ertapenem-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Clone Carries a Novel OmpK36 Porin Variant , 2010, Antimicrobial Agents and Chemotherapy.

[31]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[32]  D. Hamer,et al.  High Frequency of Multidrug-Resistant Gram-Negative Rods in 2 Neonatal Intensive Care Units in the Philippines , 2009, Infection Control & Hospital Epidemiology.

[33]  T. Walsh.  Clinically significant carbapenemases: an update , 2008, Current opinion in infectious diseases.

[34]  D. Church,et al.  Burn Wound Infections , 2006, Clinical Microbiology Reviews.

[35]  N. Høiby,et al.  OXA-type carbapenemases. , 2006, The Journal of antimicrobial chemotherapy.

[36]  M. Souli,et al.  First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1 , 2004 .

[37]  I. Burney,et al.  Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan. , 2004, JPMA. The Journal of the Pakistan Medical Association.

[38]  Y. Tselentis,et al.  Spread of blaVIM-1-producing e. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase gene , 2004 .

[39]  Y. Arakawa,et al.  PCR Typing of Genetic Determinants for Metallo-β-Lactamases and Integrases Carried by Gram-Negative Bacteria Isolated in Japan, with Focus on the Class 3 Integron , 2003, Journal of Clinical Microbiology.

[40]  R. Cisterna,et al.  Simple and reliable multiplex PCR assay for detection of blaTEM, bla(SHV) and blaOXA-1 genes in Enterobacteriaceae. , 2003, FEMS microbiology letters.

[41]  P. Nordmann,et al.  Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[42]  T. Sawai,et al.  Functional Analysis of the Active Site of a Metallo-β-Lactamase Proliferating in Japan , 2000, Antimicrobial Agents and Chemotherapy.

[43]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[44]  Y. Arakawa,et al.  Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens , 1995, Antimicrobial agents and chemotherapy.

[45]  Ghulam Fatima,et al.  Imipenem Resistant Pseudomonas aeruginosa: The fall of the final quarterback , 1969, Pakistan journal of medical sciences.

[46]  Adnan Khan,et al.  Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi , 1969, Pakistan journal of medical sciences.

[47]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[48]  K. Y. AL-Aali.  Microbial Profile of Burn Wound Infections inBurn Patients, Taif, Saudi Arabia , 2016 .

[49]  J. Munita,et al.  Mechanisms of Antibiotic Resistance , 2016, Microbiology spectrum.

[50]  M. Ilyas,et al.  Frequency, Susceptibility and Co-Existence of MBL, ESBL & AmpC Positive Pseudomonas aeruginosa in Tertiary Care Hospitals of Peshawar, KPK, Pakistan , 2015 .

[51]  Sidra Shan,et al.  Detection of bla IMP Gene in Metallo-β-Lactamase Producing Isolates of Imipenem Resistant Pseudomonas aeruginosa ; an Alarming Threat , 2015 .

[52]  Sanjeev Kumar.  Performance of Modified Hodge Test and Combined Disc Test for Detection of Carbapenemases in Clinical Isolates of Enterobacteriaceae , 2015 .

[53]  Tetsuro Kato,et al.  A case of NDM-1-producing Acinetobacter baumannii transferred from India to Japan , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[54]  K. Anuradha,et al.  Phenotypic detection of ESBL and MBL in clinical isolates of Enterobacteriaceae , 2013 .

[55]  P. Nordmann,et al.  AbaR-type transposon structures in Acinetobacter baumannii. , 2012, The Journal of antimicrobial chemotherapy.

[56]  D. Zahoor,et al.  Detection of metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa at a tertiary care hospital in Kashmir , 2011 .

[57]  Y. Tselentis,et al.  Spread of bla(VIM-1)-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the bla(VIM-1) metallo-beta-lactamase gene. , 2004, Diagnostic microbiology and infectious disease.

[58]  P. Hawkey,et al.  Occurrence of a new metallo-beta-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. , 2001, FEMS microbiology letters.